نتائج البحث - "Raphaël Bernard-Valnet"

المساهمون: Pistre, Karine, Service of Neurology [CHUV, Lausanne, Switzerland], Centre Hospitalier Universitaire Vaudois [Lausanne] (CHUV), Université de Lausanne = University of Lausanne (UNIL), Neuro-Dol (Neuro-Dol), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne (UCA), CHU Clermont-Ferrand, Service de neurologie [Poitiers], Centre hospitalier universitaire de Poitiers (CHU Poitiers), Service Maladies infectieuses et tropicales [CHU Toulouse], Pôle Inflammation, infection, immunologie et loco-moteur [CHU Toulouse] (Pôle I3LM Toulouse), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Service de neurologie [Bordeaux], CHU Bordeaux [Bordeaux]-Groupe hospitalier Pellegrin, Service de médecine interne [Mondor], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Hôpital Pasteur [Nice] (CHU), Université Côte d'Azur (UCA), Pôle Neurosciences [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Service des maladies infectieuses et tropicales [Toulouse], Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse], Pôle neurosciences [Hôpital de Purpan - Toulouse], CHU Toulouse [Toulouse]

المصدر: Neurology, vol. 9, no. 1, pp. e1097
Neurology Neuroimmunology & Neuroinflammation
Neurology Neuroimmunology & Neuroinflammation, 2022, 9 (1), pp.e1097. ⟨10.1212/NXI.0000000000001097⟩
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3
Neurology Neuroimmunology & Neuroinflammation, American Academy of neurology, 2022, 9 (1), pp.e1097. ⟨10.1212/NXI.0000000000001097⟩

مصطلحات موضوعية: Male, MESH: Leukoencephalopathy, Progressive Multifocal / chemically induced, [SDV]Life Sciences [q-bio], MESH: CCR5 Receptor Antagonists / administration & dosage, Maraviroc, chemistry.chemical_compound, Natalizumab, Immune Reconstitution Inflammatory Syndrome, MESH: Immune Reconstitution Inflammatory Syndrome / chemically induced, Outcome Assessment, Health Care, [SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, MESH: Middle Aged, Progressive multifocal leukoencephalopathy, Hazard ratio, Leukoencephalopathy, Progressive Multifocal, Middle Aged, Class IV, [SDV] Life Sciences [q-bio], MESH: Maraviroc / pharmacology, Neurology, CCR5 Receptor Antagonists, Cohort, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, MESH: CCR5 Receptor Antagonists / pharmacology, Female, medicine.drug, Adult, MESH: Immune Reconstitution Inflammatory Syndrome / drug therapy, medicine.medical_specialty, MESH: Leukoencephalopathy, Progressive Multifocal / drug therapy, Article, Multiple sclerosis, Young Adult, Immune reconstitution inflammatory syndrome, Internal medicine, medicine, Humans, MESH: Outcome Assessment, Health Care, Retrospective Studies, Viral infections, MESH: Humans, business.industry, Retrospective cohort study, MESH: Retrospective Studies, Odds ratio, medicine.disease, MESH: Male, MESH: Leukoencephalopathy, Progressive Multifocal / prevention & control, chemistry, MESH: Immune Reconstitution Inflammatory Syndrome / prevention & control, Neurology (clinical), business, MESH: Female, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, CCR5 Receptor Antagonists/administration & dosage, CCR5 Receptor Antagonists/pharmacology, Immune Reconstitution Inflammatory Syndrome/chemically induced, Immune Reconstitution Inflammatory Syndrome/drug therapy, Immune Reconstitution Inflammatory Syndrome/prevention & control, Leukoencephalopathy, Progressive Multifocal/chemically induced, Leukoencephalopathy, Progressive Multifocal/drug therapy, Leukoencephalopathy, Progressive Multifocal/prevention & control, Maraviroc/administration & dosage, Maraviroc/pharmacology, MESH: Maraviroc / administration & dosage